Nuage Therapeutics is pioneering a novel drug discovery approach which allows the targeting of intrinsically disordered proteins (IDPs). Our mission is to deliver a new wave of transformational precision therapies for aggressive cancers. Nuage's pioneering approach enables the development of innovative therapies against cancer-driving transcription factors. 

Industry connector health, tech, pharma,...

I lead ecosystem development and strategic partnerships for four international summits designed to accelerate innovation across high-impact verticals. My role focuses on connecting the right people — from startups and corporates to investors and public institutions — and building collaboration formats that create long-term value.

Organaid combines patient-derived 3D organoids with ImPheNet, our proprietary AI engine, to predict drug efficacy and toxicity before a compound reaches the clinic, reducing attrition, cutting timelines, and lowering development costs at the preclinical stage.

 We are currently producing central nervous system organoids and, from September onwards, we will scale to industrial-level production at the Parc Científic of Barcelona (Spain), expanding our portfolio to additional organ systems and regenerative medicine.

El Parc de Recerca fomenta la innovació empresarial connectant empreses amb recursos acadèmics d'avantguarda de la UAB. Oferim accés a investigacions punteres, col·laboració en R+D, networking i una xarxa de talent, tot facilitant el desenvolupament i la incubació d'empreses innovadores. Així, transformem el coneixement en solucions tangibles que impulsen el creixement i la competitivitat.

Peptomyc is a spin-off from the Vall d’Hebron Institute of Oncology (VHIO) that is revolutionizing cancer treatment: we are the only company that uses mini-protein therapeutics to directly inhibit MYC – the central engine for cancer proliferation, survival, and resistance to treatment. Doing so, Peptomyc offers a foundational treatment to any cancer patient with abnormal MYC activity, improving patient’ survival and quality of life.

Perdigó Medical is Barcelona's only specialised medical device development consultancy.

With over a decade of experience and 100+ projects delivered, we have built a reputation as the trusted development partner for innovators across Catalonia, Spain and Europe. Our clients range from promising local startups, including Heecap, Nimble Dx, and The Blue Box to global industry leaders such as AstraZeneca, Merck, and Alcon.

As an ISO 13485-certified organisation, we accompany projects from phase 0 to market launch and beyond. Perdigó Medical covers the full journey, under one roof to ensure as little friction and risk as possible.

Our expertise spans across medtech: medical devices, in vitro diagnostics, drug delivery, surgical instruments, IVF, biotech manufacturing, and more. It is precisely this breadth, combined with our exclusive focus on medical devices, that makes us the partner of choice for innovators who need a team with the experience to rely on — one that has seen it before, across sectors and stages.

Prasfarma is a CMO/CDMO specialized in the development and GMP manufacturing of high-potency and oncology products, with a strong focus on sterile injectable and lyophilized formulations.

We provide end-to-end support from early clinical stages to commercial supply, operating under EU GMP Annex 1 standards with advanced isolator technology.

Our approach combines flexibility, technical expertise, and innovation to support complex pharmaceutical projects.

Qualirion Software Solutions es una consultora y desarrolladora tecnológica española especializada en la transformación digital para empresas y la implantación de soluciones de IA.

Sus pilares principales son:

• Desarrollo e implantación de soluciones de IA

• Automatización e integración de sistemas, flujos y procesos para empresas

• Desarrollo a medida: Creación de software, aplicaciones móviles (iOS/Android) y plataformas web (e-commerce, SaaS) personalizadas.

• Soluciones de Gestión (ERP/CRM): Implementación de sistemas para automatizar finanzas, ventas, inventario y recursos humanos.

• Especialización por sectores: Ofrecen soluciones verticales específicas para sectores como Salud (gestión de clínicas, agendas, historiales), HORECA (TPV para hostelería y restauración) e Industria (automatización de procesos y optimización de planta).

• Infraestructura y Cloud: Servicios de servidores de alto rendimiento, ciberseguridad y soluciones en la nube.

Especializados en los sectores Químico, Pharma e Indústria.

RidNova is a biopharmaceutical company dedicated to addressing health challenges and driving innovation in pharmaceuticals, biosimilars, and biologics, to improve patient outcomes. We specialise in formulation development, formulation consulting, analytical and commercial manufacturing, leveraging state-of-the-art technologies and extensive industry expertise. We offer comprehensive product and dossier development and formulation, regulatory & CMC consultancy, advisory services in complex formulation, biosimilars, biologicals, 505 b (2)/hybrid, differentiated, innovative, value-added formulations to Pharma, CDMO, small biotech/startups for formulation, as well as guidance on regulatory strategy. RidNova also provides services in IP, regulatory submissions, post-launch activities and strategic publication planning to support the successful introduction and positioning of pharmaceutical assets in the market.